[New York, N.Y., June 25, 2010] A jury in the United States District Court for the Southern District of New York found that Merck's osteoporosis drug Fosamax was defectively designed and unreasonably dangerous. As reported in the Wall St. Journal, the jury verdict raises serious questions about the safety of Fosamax for some patients. A medication widely prescribed for loss of bone density which might lead to osteoporosis, Fosamax has been linked not only to osteonecrosis of the jaw (a rotting of the jaw bone), but also more recently to serious fractures of the femur.
Release Date: 4/26/2004
Case Turns On What Constitutes Adequate Warning
By Correy E. Stephenson
In the latest Rezulin case to reach trial, a New York jury awarded $2 million to a woman who suffered side effects from the diabetes drug, but had no evidence of permanent liver damage.
With approximately 8,700 Rezulin lawsuits filed in state and federal courts across the country, the April trial was closely watched for indications of whether the mass tort is likely to be successful.
Source: Pensacola News Journal | Release Date: 4/6/2004
Settlement covers property, medical study in Agrico toxic case
Steve Mraz @ PensacolaNewsJournal.com
ConocoPhillips has agreed to a $70 million settlement with Pensacola residents whose property is potentially contaminated by a toxic plume that has spread from the old Agrico Chemical Co. fertilizer plant in central Pensacola to Bayou Texar.